MicroRNA marker | Expression level of target gene | Clinical correlation and SLE disease association | Possible mechanisms | Ref. |
---|---|---|---|---|
DNMT1-related microRNAs as a biomarker | ||||
 miR-126 |  | Positively correlated with disease activity | Induces DNA hypomethylation | |
 miR-21 |  | Positively correlated with the SLEDAI score, SLE flares, and remission |  |  |
 miR-148a | ↑(PBMCs) | Positively correlated with the SLEDAI score | Induces DNA hypomethylation | |
MicroRNA biomarkers to evaluate renal dysfunction | ||||
 miR-130b-3p | ↑(serum) | Positively correlated with renal damage | Promote EMT by targeting ERBB2IP | [121] |
 miR-26a and miR-30b | ↓(kidney and urine) | Positively correlated with disease activity | Control of mesangial cell proliferation and cell cycle-related genes | [122] |
 |  |  | Downregulate the anti-fibrotic protein suppressor of cytokine signaling 1 (SOCS1) and upregulate profibrotic proteins in both proximal tubular and mesangial cells |  |
 miR-150 | ↑(kidney) | Positive correlation with chronicity scores |  | [123] |
Extracellular vesicle miRNAs | ||||
 miR-26a | ↑(urine exosomes) ↓(glomerular) | Positive correlation with lupus nephritis, urinary protein levels | Decreased the expression of genes associated with the podocyte differentiation and formation of the cytoskeleton | [125] |
 miR-29c | ↓(urinary exosomes) | Negatively correlated with the histological chronicity index and glomerular sclerosis | Exacerbate renal fibrosis by targeting epithelial-to-mesenchymal transition and increasing the deposition of extracellular matrix | [126] |
Immune-related microRNAs as biomarkers | ||||
 miR-146a | ↓(CD4+ T cells, serum) ↑(urine) | Negative correlated with disease activity, proteinuria, lupus nephritis, GFR, histological activity index | Negative regulator in the IFN pathway | |
 | Controversial (CD4+ T cells, serum) ↑(urine) | Positively correlated with proteinuria and SLEDAI score | Aim at SHIP11 to maintain an activation threshold that allows B cells to respond to antigens | |
 miR-155 | ↓(Lymphocytes) ↑miR-142-3p (plasma) ↑miR-142-5p (renal tissue) | No correlation with disease activity | Promoting T cell activity and antibody generation |  |
 hsa-miR-142 |  | Negatively correlated with the SLEDAI score, lupus nephritis (GFR and creatinine ratio) | Increased level of inflammatory chemokine regulated on activation, normal T cells expressed and secreted (RANTES) in SLE T cells | |
 miR-125a | ↓(CD4+ T cells, urine) |  |  | |
 miR-31 | ↓(T cell) | Negatively associated with diseases activity and urine protein | Reduced expression of IL-2 | |
 miR-21 | ↑(T cell) | Positively associated with diseases activity and urine protein | T cell activation | [139] |
MicroRNA biomarkers to classify disease phenotype | ||||
 hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p | ↑(plasma) | hsa-miR-223-3p is connected to oral ulcer and lupus anticoagulant Positively associated with serous cavity effusion. CRP and anti-Clq antibody | Not mentioned | [141] |
 miR-326 | ↑(Treg) | Regulating immune cell function | [142] |